UnitedHealth Group (NYSE:UNH) Releases FY 2024 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 27.500-27.750 for the period, compared to the consensus estimate of 27.700. The company issued revenue guidance of -.

UnitedHealth Group Stock Up 1.6 %

Shares of UNH opened at $607.55 on Tuesday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock’s 50 day moving average is $584.39 and its two-hundred day moving average is $532.15. The firm has a market cap of $561.02 billion, a P/E ratio of 40.29, a PEG ratio of 1.66 and a beta of 0.58. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the prior year, the business earned $6.14 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Analysts predict that UnitedHealth Group will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.38%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 55.70%.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Robert W. Baird upped their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an outperform rating in a report on Wednesday, July 17th. StockNews.com cut UnitedHealth Group from a buy rating to a hold rating in a research note on Wednesday, September 25th. Truist Financial lifted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a buy rating in a research report on Wednesday, July 17th. UBS Group increased their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a buy rating in a research report on Thursday, July 18th. Finally, Morgan Stanley upped their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an overweight rating in a research note on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of Buy and a consensus target price of $617.37.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.